An observational study in Food Hypersensitivity, Anaphylaxis and Eosinophilic Esophagitis, sponsored by Food Allergy Research & Education. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2025-03-12.
Sponsored by Food Allergy Research & Education · Observational
The FARE Patient Registry will serve as a prospective, observational food allergy reporting system that stores detailed health and other basic information about patients' real-world experiences with food allergies, to encourage open sharing of de-identified data and participation in clinical trials. The FARE Patient Registry intends to make and support scientific discoveries by enabling the food allergy community to participate directly in research.
376 studies on the registry are indexed under Food Hypersensitivity; 90 are open to participants now.
This study's planned enrollment of 23,000 is above the median of 151 across 120 observational studies indexed under Food Hypersensitivity.
Browse Food Hypersensitivity studies →This is the only study on the registry with Food Allergy Research & Education as lead sponsor.
Counted across the registry records on this site, refreshed daily.
The population includes males and females of all ages with one or more food allergy or those who are at risk of food-induced anaphylaxis.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Create a registry to characterize the extent of food allergy, its etiology and other factors that contribute to disease development.
Time frame: 2023
Plan to share: Undecided
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.